stars 1 stars 2 stars 3

Phinomics is unlocking a hidden layer of biology—circular DNA and cryptic proteins—to power the next generation of AI in precision medicine. While others models train on a static, 1-D linear genome, we see a 3D, dynamic ecosystem of disease-driving elements. Our platform decodes and quantifies these overlooked signals and integrates them into high-resolution, multimodal maps of disease biology—connecting circular DNA with expression, epigenetics, and clinical outcomes. But the real breakthrough isn’t just better data—it’s what we do with it. Phinomics trains AI on orthogonal, causal, and clinically validated signals that go far beyond conventional inputs. The result is biological intelligence that understands disease from the inside out, powering new models for prediction, precision, and cure. That’s Phinomics. The lens into biology no one else has and the data engine that will power the future of precision medicine.

Phinomics Questions

Guido Mathews is the Chief Business Officer of Phinomics.

7 people are employed at Phinomics.

Top Phinomics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users